A Single Ascending Dose of HRS-2162 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Reversal of Neuromuscular Blockade

Interventions

DRUG

HRS-2162

DRUG

Placebo

Trial Locations (1)

Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors

lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY